Crispr Therapeutics Plans to Launch Its First Clinical Trial in 2018

In late 2012, French microbiologist Emmanuelle Charpentier approached a handful of American scientists about starting a company, a Crispr company. They included UC Berkeley’s Jennifer Doudna, George Church at Harvard University, and his former postdoc Feng Zhang of the Broad Institute—the brightest stars in the then-tiny field of Crispr research. Back then barely 100 papers …

Continue reading “Crispr Therapeutics Plans to Launch Its First Clinical Trial in 2018”